strategy Archives -

Long-serving Roche chief executive Severin Schwan is stepping down, to be replaced next March by Thomas Schinecker, currently

Roche CEO Severin Schwan to stand down after 14 years

https://pharmaphorum.com/news/roche-ceo-severin-schwan-to-stand-down-after-14-years/

Digital/ Partner content/ Press releases

Report: Omnichannel advice for the life science industry

Fishawack Marketing #medcomms, biopharma, healthcare, omnichannel, strategy 0 Comment

In the healthcare sector and beyond, the adoption of digital tools and novel analytics has exploded. However, unlike

Report: Omnichannel advice for the life science industry

https://pharmaphorum.com/partner-content/report-omnichannel-advice-for-the-life-science-industry/

6 critical success factors for flawless execution of a rapid first commercial launch

Partner Content/ Partner content/ Press releases

6 critical success factors of a successful rapid first commercial launch

Fishawack Marketing digital, pharma, rapid launch, strategy 0 Comment

Annemarie Armstrong shares key factors for rapid launch

6 critical success factors of a successful rapid first commercial launch

https://pharmaphorum.com/partner-content/6-critical-success-factors-of-a-successful-rapid-first-commercial-launch/

News/ News/ Sales and Marketing

J&J finally decides to dismantle its diversified business model

Phil Taylor consumer health, Johnson & Johnson, M&A, strategy 0 Comment

After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off

J&J finally decides to dismantle its diversified business model

https://pharmaphorum.com/news/jj-finally-decides-to-dismantle-its-diversified-business-model/

loe_pwire_784_x_523.736x0-is_pharmaphorum

Partner content/ Press releases

Three strategies for managing loss of exclusivity successfully

Fishawack Marketing AstraZeneca, Eli Lilly, loss of exclusivity, Pfizer, strategy 0 Comment

“Patent losses could sink Allergan”.1 “Drug prices to plummet in wave of expiring patents”.2 “Price decay after loss

Three strategies for managing loss of exclusivity successfully

https://pharmaphorum.com/partner-content/three-strategies-for-managing-loss-of-exclusivity-successfully-2/

Appointments/ Partner content/ Sales and Marketing

Prescient Announces Recent Appointments to its Senior Team

cmaffei@prescienthg.com Commerical, Insights, intelligence, pharma, strategy 0 Comment

Prescient hires two new senior members to Senior Team

Prescient Announces Recent Appointments to its Senior Team

https://pharmaphorum.com/partner-content/prescient-announces-recent-appointments-to-its-senior-team/

Appointments/ Partner content

Prescient Intelligence & Insight Announces Recent Appointments to the Senior Team

cmaffei@prescienthg.com biopharma, insight, intelligence, strategy 0 Comment

Prescient Intelligence & Insight hires 3 senior leads

Prescient Intelligence & Insight Announces Recent Appointments to the Senior Team

https://pharmaphorum.com/partner-content/prescient-intelligence-insight-announces-recent-appointments-to-the-senior-team-2/

News/ News/ Sales and Marketing

Merck to spin old drugs into ‘NewCo’ focused on generics, women’s health

Phil Taylor biosimilar, generic, Merck & Co, strategy, women's health 0 Comment

Merck & Co has followed the lead of other big pharma groups like Pfizer and GlaxoSmithKline by hiving

Merck to spin old drugs into ‘NewCo’ focused on generics, women’s health

https://pharmaphorum.com/news/merck-to-spin-old-drugs-into-newco-focused-on-generics-womens-health/

News/ News/ R&D

GSK must continue to improve R&D, says CEO Walmsley

Richard Staines GlaxoSmithKline, R&D, strategy 0 Comment

It’s been two and a half years since Emma Walmsley took over as CEO of GlaxoSmithKline, and at

GSK must continue to improve R&D, says CEO Walmsley

https://pharmaphorum.com/news/gsk-must-continue-to-improve-rd-says-ceo-walmsley/

Trending

strategy

Login